MGAT3-AS1: MGAT3-AS1 is an intronic antisense long non-coding RNA that has been investigated for its potential to predict delayed allograft function after kidney transplantation [PMC6791892]. The frequency distribution of MGAT3-AS1 at the first postoperative day has been shown in a figure [PMC6791892]. Receiver-operator characteristics analysis demonstrated that preoperative MGAT3-AS1 can predict delayed graft function, with an AUC of 0.83 and a 95% CI of 0.65 to 1.00 [PMC6791892]. The specific primers used for quantitative real-time RT-PCR to measure MGAT3-AS1 expression were provided in the text [PMC6791892]. The study suggests that MGAT3-AS1 could serve as a potential biomarker for short-term transplantation outcomes in patients with deceased donor kidneys at risk of delayed graft function [PMC7168890]. Furthermore, the levels of MGAT3-AS1 in mononuclear cells during the first postoperative month were shown in a figure, indicating its potential role as a biomarker during this period [PMC6791892]. Lower levels of MGAT3-AS1 may indicate reduced phagocytosis and impaired innate immune response, leading to delayed clearance of impaired renal tissue after transplantation [PMC6791892]. MGAT3-AS1 is known to regulate glycoprotein oligosaccharides in mononuclear cells, which are involved in innate immunity processes [PMC7710814]. In conclusion, MGAT3-AS is an intronic antisense long non-coding RNA that shows promise as a biomarker for predicting delayed allograft function after kidney transplantation and may be involved in regulating glycoprotein oligosaccharides and innate immunity processes [PMC7168890][PMC7710814].